1. Is Acetylsalicylic Acid a Safe and Potentially Useful Choice for Adult Patients with COVID-19 ?

   • Vanessa Bianconi
   • Francesco Violi
   • Matteo Pirro

   Current Opinion Open access 23 July 2020 Pages: 1383 - 1396

   

2. Current Status of Antisense Oligonucleotide-Based Therapy in Neuromuscular Disorders

   • Flavien Bizot
   • Adeline Vulin
   • Aurélie Goyenvalle

   Review Article 01 August 2020 Pages: 1397 - 1415

   

3. Correction to: Current Status of Antisense Oligonucleotide-Based Therapy in Neuromuscular Disorders

   • Flavien Bizot
   • Adeline Vulin
   • Aurélie Goyenvalle

   Correction 04 August 2020 Pages: 1417 - 1417

4. Peripheral Enthesitis in Spondyloarthritis: Lessons from Targeted Treatments

   • Gurjit S. Kaeley
   • Jaspreet K. Kaler

   Review Article 27 July 2020 Pages: 1419 - 1441

   

5. The Expanding Role of the COX Inhibitor/Opioid Receptor Agonist Combination in the Management of Pain

   • Giustino Varrassi
   • Cheng Teng Yeam
   • Antonella Paladini

   Review Article Open access 04 August 2020 Pages: 1443 - 1453

   

6. Daratumumab: A Review in Combination Therapy for Transplant-Eligible Newly Diagnosed Multiple Myeloma

   • Yvette N. Lamb

   Adis Drug Evaluation 16 September 2020 Pages: 1455 - 1464

   

7. Rivaroxaban: A Review for Secondary CV Prevention in CAD and PAD

   • Lesley J. Scott

   Adis Drug Evaluation 10 September 2020 Pages: 1465 - 1475

   

8. Satralizumab: First Approval

   • Young-A Heo

   AdisInsight Report Open access 14 August 2020 Pages: 1477 - 1482

   

9. Correction to: Satralizumab: First Approval

   • Young-A Heo

   Correction Open access 09 September 2020 Pages: 1483 - 1483

10. Fostemsavir: First Approval

    • Anthony Markham

    AdisInsight Report 27 August 2020 Pages: 1485 - 1490

    

11. Daprodustat: First Approval

    • Sohita Dhillon

    AdisInsight Report 03 September 2020 Pages: 1491 - 1497

    

12. Comment on: “Pharmaco-Immunomodulatory Therapy in COVID-19”

    • Dimitrios A. Vrachatis
    • Sotiria G. Giotaki
    • Bernhard Reimers

    Letter to the Editor 03 September 2020 Pages: 1499 - 1500

13. Authors’ Reply to Vrachatis et al. “Pharmaco-Immunomodulatory Therapy in COVID-19”

    • John G. Rizk
    • Kamyar Kalantar-Zadeh
    • Donald N. Forthal

    Letter to the Editor 03 September 2020 Pages: 1501 - 1503

14. Correction to: Risankizumab: A Review in Moderate to Severe Plaque Psoriasis

    • Hannah A. Blair

    Correction Open access 02 September 2020 Pages: 1505 - 1505

15. Correction to: Delafloxacin: A Review in Acute Bacterial Skin and Skin Structure Infections

    • L. J. Scott

    Correction Open access 18 September 2020 Pages: 1507 - 1507